China NMPA Draft GMP Inspection Guideline: Risk-Based Audits and Critical Check Items

China's NMPA has released a draft 'Guideline for Inspection under the Medical Device Good Manufacturing Practices', signaling a major shift towards a risk-based, lifecycle-oriented audit approach. This episode breaks down the implications of this new framework, released for comment on June 9, 2026. We detail the importance of the 39 newly designated "critical check items" and explain how a failure in any one of these areas could lead to severe regulatory consequences. We also provide practical, actionable steps for manufacturers to prepare their quality management systems for these more stringent and focused inspections. Key Questions: - What is the significance of China's NMPA draft 'Guideline for Inspection under the Medical Device Good Manufacturing Practices'? - How does the new guideline shift the focus of NMPA inspections? - What are the 39 critical check items, and why are they so important for manufacturers? - What happens if a manufacturer fails an inspection on a critical item? - How does this new approach affect both domestic and overseas medical device manufacturers? - What specific steps should regulatory and quality teams take to prepare for these new risk-based audits? - Why is a lifecycle-oriented approach to quality management now more critical than ever for the Chinese market? - How can manufacturers leverage their existing risk management files to demonstrate compliance? Sources: - https://www.chinameddevice.com/nmpa-roundup-202607/ How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies seeking to navigate complex markets like China. Our local experts and advanced AI tools streamline the market access process, from developing an effective regulatory strategy to compiling technical dossiers and preparing for NMPA audits under new guidelines like the GMP inspection framework. We help ensure your quality management system is robust and ready for risk-based inspections, minimizing delays and compliance risks. To learn more about how we can accelerate your global expansion, visit us at https://pureglobal.com, contact us at [email protected], or explore our free AI tools and database at https://pureglobal.ai.